Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Copy-number analysis identified new prognostic marker in acute myeloid leukemia.

Leukemia - 1 Mar 2017

Nibourel O, Guihard S, Roumier C, Pottier N, Terre C, Paquet A, Peyrouze P, Geffroy S, Quentin S, Alberdi A, Abdelali R B, Renneville A, Demay C, Celli-Lebras K, Barbry P, Quesnel B, Castaigne S, Dombret H, Soulier J, Preudhomme C, Cheok M H

Abstract excerpt

Recent advances in genomic technologies have revolutionized acute myeloid leukemia (AML) understanding by identifying potential novel actionable genomic alterations. Consequently, current risk stratification at diagnosis not only relies on cytogenetics, but also on the inclusion of several of these abnormalities. Despite this progress, AML remains a heterogeneous and complex malignancy with variable response to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to DNA Copy Number Variations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Neoplasm

Share to Gene Dosage

Share to Genes, p53

Share to Genomics

Share to Leukemia, Myeloid, Acute

Share to Proportional Hazards Models

Source

Identifiers

PMID: 27686867
DOI: 10.1038/leu.2016.265

Genes

ERG

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Copy-number analysis identified new prognostic marker in acute myeloid leukemia.PMID 27686867Read ↗

Genomic analysis of acute myeloid leukemia: potential for new prognostic indicators.Semantic proximity Read ↗

Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome.Semantic proximity Read ↗

Mutational landscape of AML with normal cytogenetics: biological and clinical implications.Semantic proximity Read ↗

Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemia.Semantic proximity Read ↗

Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children's Oncology Group report.Semantic proximity Read ↗

Acquired copy number alterations in adult acute myeloid leukemia genomes.Semantic proximity Read ↗

DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes InvolvedSemantic proximity Read ↗

Molecular prognostic factors in cytogenetically normal acute myeloid leukemia.Semantic proximity Read ↗

Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics.Semantic proximity Read ↗

Chromosome aberrations, gene mutations and expression changes, and prognosis in adult acute myeloid leukemia.Semantic proximity Read ↗

Close correlation of copy number aberrations detected by next-generation sequencing with results from routine cytogenetics in acute myeloid leukemia.Semantic proximity Read ↗

Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advancesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.